Jalon(SH:688357) Ge Long Hui·2026-02-26 09:41Core Viewpoint - The company reported a steady growth in revenue and profit for the year 2025, driven by its focus on innovation and expansion into new materials and technology services while maintaining its core business in molecular sieve adsorbents [1]. Group 1: Financial Performance - The company achieved an operating revenue of 841 million yuan, representing a year-on-year increase of 7.97% [1]. - The net profit attributable to shareholders reached 98.52 million yuan, up 31.79% year-on-year [1]. - The net profit after deducting non-recurring gains and losses was 94.65 million yuan, reflecting a significant growth of 55.75% [1]. - The gross profit margin improved to 31.92%, an increase of 3.57 percentage points compared to the same period last year [1]. Group 2: Business Operations - The company maintained a competitive advantage in the fields of gas separation, medical oxygen production, and adsorption drying, leading to increased sales revenue [1]. - Effective cost control measures contributed to the steady recovery of the gross profit margin, supporting future technology research and industrial expansion [1]. - The overseas sales revenue amounted to 216.92 million yuan, marking a year-on-year growth of 9.00%, accounting for 25.80% of total revenue [1]. - The stable operation of overseas bases enhanced the company's ability to respond to changes in the international trade environment and laid a foundation for further market expansion [1]. Group 3: Future Strategy - In 2026, the company will continue to focus on dual-driven development in domestic and international markets, emphasizing four key areas: petrochemicals, energy chemicals, renewable resources, and renewable energy [2]. - The company aims to steadily transition its business model from new material manufacturing to comprehensive technical services, fully empowering its high-quality development [2].